Work

Detection of FGFR3 alt in plasma cfDNA in metastatic UC patients receiving Erda therapy.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.e16519

Authors: Michal Sarfaty, Min Yuen Teo, Samuel Aaron Funt, Chung-Han Lee, David Henry Aggen, Neha Ratna, Ashley Marie Regazzi, Andrew Thomas Lenis, Ziyu Chen, Hikmat A. Al-Ahmadie, Angela Rose Brannon, Michael F. Berger, David B. Solit, Jonathan E. Rosenberg, Dean F. Bajorin, Gopa Iyer

Institutions: Memorial Sloan Kettering Cancer Center, Columbia University Irving Medical Center

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W3166584471

Cites:

Cited by:

Related to: 10